The proliferation of cancer cells depends on a complex interplay of molecular pathways. Recent research has pinpointed KAS138, an enzyme, as a promising therapeutic target in the struggle against various types of cancer. KAS138 is linked in several crucial cellular processes, including cellular signaling. Dysregulation of KAS138 activity has been